The Hungarian dietary supplement manufacturer BioTechUSA, headquartered in Szada, has completed nearly two-thirds of the largest investment program in its history. Out of the planned HUF 9 billion (EUR 22.5 million), HUF 5.5 billion (EUR 13.75 million) has already been spent.
Most recently, the company inaugurated a complex production line for protein bars and a labeling facility at its production and logistics center. BioTechUSA now operates on 45,000 square meters, with a storage capacity of 24,000 pallets, producing 75 million protein bars, 20,000 tons of protein powder, and 1 billion capsules and tablets annually.
In 2024, BioTechUSA launched 25 new products, opened 20 new stores, expanded its market presence to 103 countries, and signed a cooperation agreement with FC Barcelona. The company’s revenue increased by nearly HUF 10 billion (EUR 25 million) last year, reaching HUF 93.7 billion (EUR 234 million).